Patient Recliners Market Demand & Trends

Request Methodology

Patient Recliners Market Outlook (2022-2032)

[342 Pages Report] The global patient recliners market is valued at about US$ 14.8 Billion in 2022. As per the estimates, the patient recliners market size is likely to reach a net worth of US$ 35.1 Billion by the year 2032, by growing at a CAGR of 8.1% during the forecast period (2022-2032).

Report Attribute	Details
Patient Recliners Market Size Value (2022)	US$ 14.8 Billion
Patient Recliners Market Share Anticipated Forecast Value (2032)	US$ 35.1 Billion
Projected Patient Recliners Market Growth Rate (2022-2032)	8.1%

The patient recliner is an important furniture staple of the patient rooms and is becoming common in hospitals, patient examination areas, physician’s offices, and therapy centres. These patient recliners or recliner chairs provide many benefits for short-term as well as long-term patients by maximizing their comfort.

The growing demand for patient recliners witnessed in the present-day healthcare sector was first developed and used by La-Z-Boy, but the design was bulky and somewhat complicated. Despite this, the earliest design is still dominant and has shown a little evolution, as evident from the sales of patient recliners achieved in the contemporary market.

Functional challenges were due to bulky arms and footprint, which were solved after the introduction of Nemschoff’s award-winning patient recliner AVA, which has significantly strengthened the patient recliner market share.

The current global patient recliners market makes available a variety of products with different features such as posture-correct lumbar and lateral cushioning and wire-spring construction for easy suspension. Anti-bacterial easy cleaning polyvinyl cushioning, etc., are some of the recent adoptions that have boosted the sales of patient recliners as well.

Demand for patient recliners is increasing for a variety of sizes and functions, including deep recline and adjustable suspension. The need for providing stress reduction and improvement of blood circulation in the limbs has also surged the sales of patient recliners in the last couple of years.

Over the projection period, the patient room recliners sector is anticipated to generate the most revenue. Load capacity, adaptability, and improved comfort for both the inpatient and staff are to blame for the higher sales of patient recliners in this segment. The demand for patient recliners in the bariatric recliners segment, on the other hand, is anticipated to witness a sharp rise during the projected years.

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

What Are Some Of The Prominent Drivers & Restraints In The Patient Recliners Market?

Increased safety for both patients as well as caregivers is the prime requirement of any medical equipment that is generating a huge demand for patient recliners as well. The global patient recliners market is expected to witness steady and continuous growth over the forecast period of 2017–2027 due to the growing number of private as well as public healthcare facilities across the globe.

Sales of patient recliners for home care settings are expected to increase with increasing disposable income and to improve the standard of living in both developed as well as emerging markets.

Expanding aging population and higher footfall in hospitals are the major factors driving the sales of patient recliners market over the last few years. Technological advancements and enhanced functionality of modern assets would significantly drive the demand for patient recliners over the forecast period.

For instance, ergonomically mapped recliners designed to relieve pressure are widely getting adopted by the US patient recliners market share these days. However, most of the sales of patient recliners in today’s market are achieved by typical ones that are hard to move despite the fact that they are equipped with casters.

Moreover, aesthetic and functional issues are also limiting the demand for patient recliners by healthcare institutions. However, recent advances have made the shifting of patients from recliners to wheelchairs, beds, or other patient transfer devices easier, which has supplemented the demand for patient recliners further.

How Is The Performance Of Patient Recliners Market In Different Geographical Regions?

Geographically, the demand for patient recliners is highest in the North America region, accounting for almost 37.5% achieved globally. The US clearly dominates the global patient recliners market due to the highest standard of healthcare. Europe is figured out to be the second-largest market for sales of patient recliners contributing to nearly 33.4% due to more number of key players operating in the region.

Asia Pacific patient recliners market is expected to witness considerable growth in demand for patient recliners due to rapid acceptance of these products by the growing aging population. Higher installation and maintenance costs are the major factors and challenges for the sales of patient recliners in Asia Pacific countries.

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Who Are Some Of The Prominent Players In The Patient Recliners Market?

Some of the popular players in the patient recliners market include Jordan Active Patient Recliner (Krug Inc.), Ava, Serenity (Nemschoff), Accord Wieland, versant (Sauder MFG Co.), Affina, Perth, Soltice (KI), and Symmetry Plus (Stryker) among others.

Report Scope

Report Attribute	Details
Growth Rate	CAGR of 8.1% from 2022 to 2032
Base Year for Estimation	2021
Historical Data	2016-2021
Forecast Period	2022-2032
Quantitative Units	Revenue in US$ Million and CAGR from 2022-2032
Report Coverage	Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis
Segments Covered	Indication End user Region
Regions Covered	North America Latin America Europe East Asia South Asia Oceania Middle East and Africa
Key Countries Profiled	USA Canada Brazil Argentina Germany UK France Spain Italy Nordics BENELUX Australia & New Zealand China India ASEAN GCC South Africa
Key Companies Profiled	Jordan Active Patient Recliner (Krug Inc.) Ava, Serenity (Nemschoff) Accord Wieland Versant (Sauder MFG Co.) Affina Perth Soltice (KI) Symmetry Plus (Stryker)
Customization	Available Upon Request

Frequently Asked Questions

What is the Growth Outlook for the Patient Recliners Market?

The global patient recliners market is set to advance at a CAGR of 8.1% from 2022 to 2032.

Which is the Estimated Patient Recliners Market Share of North America?

North America dominates patient recliners market share of 37.5% through 2032.

What is the Future of the Patient Recliners Market?

The patient recliners market is likely to reach a valuation of US$ 35.1 Billion by 2032.

Table of Content

1. Executive Summary

1.1. Global Market Outlook

1.2. Demand-side Trends

1.3. Supply-side Trends

1.4. Technology Roadmap Analysis

1.5. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

3. Market Background

3.1. Market Dynamics

3.1.1. Drivers

3.1.2. Restraints

3.1.3. Opportunity

3.1.4. Trends

3.2. Scenario Forecast

3.2.1. Demand in Optimistic Scenario

3.2.2. Demand in Likely Scenario

3.2.3. Demand in Conservative Scenario

3.3. Opportunity Map Analysis

3.4. Investment Feasibility Matrix

3.5. PESTLE and Porter’s Analysis

3.6. Regulatory Landscape

3.6.1. By Key Regions

3.6.2. By Key Countries

3.7. Regional Parent Market Outlook

4. Global Market Analysis 2017-2021 and Forecast, 2022-2032

4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021

4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032

4.2.1. Y-o-Y Growth Trend Analysis

4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Indication

5.1. Introduction / Key Findings

5.2. Historical Market Size Value (US$ Mn) Analysis By Indication, 2017-2021

5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Indication, 2022-2032

5.3.1. Cardiac Care Recliners

5.3.2. Bariatric Recliners

5.3.3. Patient Room/Lounge Recliners

5.3.4. Others

5.4. Y-o-Y Growth Trend Analysis By Indication, 2017-2021

5.5. Absolute $ Opportunity Analysis By Indication, 2022-2032

6. Global Market Analysis 2017-2021 and Forecast 2022-2032, By End User

6.1. Introduction / Key Findings

6.2. Historical Market Size Value (US$ Mn) Analysis By End User, 2017-2021

6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By End User, 2022-2032

6.3.1. Hospitals

6.3.2. Clinics

6.3.3. Dialysis Centers

6.3.4. Nursing Homes

6.3.5. Home Care Settings

6.3.6. Other Healthcare Facilities

6.4. Y-o-Y Growth Trend Analysis By End User, 2017-2021

6.5. Absolute $ Opportunity Analysis By End User, 2022-2032

7. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Region

7.1. Introduction

7.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021

7.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032

7.3.1. North America

7.3.2. Latin America

7.3.3. Europe

7.3.4. Asia Pacific

7.3.5. MEA

7.4. Market Attractiveness Analysis By Region

8. North America Market Analysis 2017-2021 and Forecast 2022-2032, By Country

8.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

8.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

8.2.1. By Country

8.2.1.1. US

8.2.1.2. Canada

8.2.2. By Indication

8.2.3. By End User

8.3. Market Attractiveness Analysis

8.3.1. By Country

8.3.2. By Indication

8.3.3. By End User

8.4. Key Takeaways

9. Latin America Market Analysis 2017-2021 and Forecast 2022-2032, By Country

9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

9.2.1. By Country

9.2.1.1. Brazil

9.2.1.2. Mexico

9.2.1.3. Rest of Latin America

9.2.2. By Indication

9.2.3. By End User

9.3. Market Attractiveness Analysis

9.3.1. By Country

9.3.2. By Indication

9.3.3. By End User

9.4. Key Takeaways

10. Europe Market Analysis 2017-2021 and Forecast 2022-2032, By Country

10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

10.2.1. By Country

10.2.1.1. Germany

10.2.1.2. U.K.

10.2.1.3. France

10.2.1.4. Spain

10.2.1.5. Italy

10.2.1.6. Rest of Europe

10.2.2. By Indication

10.2.3. By End User

10.3. Market Attractiveness Analysis

10.3.1. By Country

10.3.2. By Indication

10.3.3. By End User

10.4. Key Takeaways

11. Asia Pacific Market Analysis 2017-2021 and Forecast 2022-2032, By Country

11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

11.2.1. By Country

11.2.1.1. China

11.2.1.2. Japan

11.2.1.3. South Korea

11.2.1.4. Rest of Asia Pacific

11.2.2. By Indication

11.2.3. By End User

11.3. Market Attractiveness Analysis

11.3.1. By Country

11.3.2. By Indication

11.3.3. By End User

11.4. Key Takeaways

12. MEA Market Analysis 2017-2021 and Forecast 2022-2032, By Country

12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

12.2.1. By Country

12.2.1.1. GCC Countries

12.2.1.2. South Africa

12.2.1.3. Israel

12.2.1.4. Rest of MEA

12.2.2. By Indication

12.2.3. By End User

12.3. Market Attractiveness Analysis

12.3.1. By Country

12.3.2. By Indication

12.3.3. By End User

12.4. Key Takeaways

13. Key Countries Market Analysis

13.1. US

13.1.1. Pricing Analysis

13.1.2. Market Share Analysis, 2021

13.1.2.1. By Indication

13.1.2.2. By End User

13.2. Canada

13.2.1. Pricing Analysis

13.2.2. Market Share Analysis, 2021

13.2.2.1. By Indication

13.2.2.2. By End User

13.3. Brazil

13.3.1. Pricing Analysis

13.3.2. Market Share Analysis, 2021

13.3.2.1. By Indication

13.3.2.2. By End User

13.4. Mexico

13.4.1. Pricing Analysis

13.4.2. Market Share Analysis, 2021

13.4.2.1. By Indication

13.4.2.2. By End User

13.5. Germany

13.5.1. Pricing Analysis

13.5.2. Market Share Analysis, 2021

13.5.2.1. By Indication

13.5.2.2. By End User

13.6. U.K.

13.6.1. Pricing Analysis

13.6.2. Market Share Analysis, 2021

13.6.2.1. By Indication

13.6.2.2. By End User

13.7. France

13.7.1. Pricing Analysis

13.7.2. Market Share Analysis, 2021

13.7.2.1. By Indication

13.7.2.2. By End User

13.8. Spain

13.8.1. Pricing Analysis

13.8.2. Market Share Analysis, 2021

13.8.2.1. By Indication

13.8.2.2. By End User

13.9. Italy

13.9.1. Pricing Analysis

13.9.2. Market Share Analysis, 2021

13.9.2.1. By Indication

13.9.2.2. By End User

13.10. China

13.10.1. Pricing Analysis

13.10.2. Market Share Analysis, 2021

13.10.2.1. By Indication

13.10.2.2. By End User

13.11. Japan

13.11.1. Pricing Analysis

13.11.2. Market Share Analysis, 2021

13.11.2.1. By Indication

13.11.2.2. By End User

13.12. South Korea

13.12.1. Pricing Analysis

13.12.2. Market Share Analysis, 2021

13.12.2.1. By Indication

13.12.2.2. By End User

13.13. GCC Countries

13.13.1. Pricing Analysis

13.13.2. Market Share Analysis, 2021

13.13.2.1. By Indication

13.13.2.2. By End User

13.14. South Africa

13.14.1. Pricing Analysis

13.14.2. Market Share Analysis, 2021

13.14.2.1. By Indication

13.14.2.2. By End User

13.15. Israel

13.15.1. Pricing Analysis

13.15.2. Market Share Analysis, 2021

13.15.2.1. By Indication

13.15.2.2. By End User

14. Market Structure Analysis

14.1. Competition Dashboard

14.2. Competition Benchmarking

14.3. Market Share Analysis of Top Players

14.3.1. By Regional

14.3.2. By Indication

14.3.3. By End User

15. Competition Analysis

15.1. Competition Deep Dive

15.1.1. Stryker Corporation

15.1.1.1. Overview

15.1.1.2. Product Portfolio

15.1.1.3. Profitability by Market Segments

15.1.1.4. Sales Footprint

15.1.1.5. Strategy Overview

15.1.1.5.1. Marketing Strategy

15.1.2. Medline Industries Inc.

15.1.2.1. Overview

15.1.2.2. Product Portfolio

15.1.2.3. Profitability by Market Segments

15.1.2.4. Sales Footprint

15.1.2.5. Strategy Overview

15.1.2.5.1. Marketing Strategy

15.1.3. Regency Healthcare

15.1.3.1. Overview

15.1.3.2. Product Portfolio

15.1.3.3. Profitability by Market Segments

15.1.3.4. Sales Footprint

15.1.3.5. Strategy Overview

15.1.3.5.1. Marketing Strategy

15.1.4. Steelcase Inc.

15.1.4.1. Overview

15.1.4.2. Product Portfolio

15.1.4.3. Profitability by Market Segments

15.1.4.4. Sales Footprint

15.1.4.5. Strategy Overview

15.1.4.5.1. Marketing Strategy

15.1.5. Krueger International

15.1.5.1. Overview

15.1.5.2. Product Portfolio

15.1.5.3. Profitability by Market Segments

15.1.5.4. Sales Footprint

15.1.5.5. Strategy Overview

15.1.5.5.1. Marketing Strategy

15.1.6. Sauder MFG

15.1.6.1. Overview

15.1.6.2. Product Portfolio

15.1.6.3. Profitability by Market Segments

15.1.6.4. Sales Footprint

15.1.6.5. Strategy Overview

15.1.6.5.1. Marketing Strategy

15.1.7. Nemschoff

15.1.7.1. Overview

15.1.7.2. Product Portfolio

15.1.7.3. Profitability by Market Segments

15.1.7.4. Sales Footprint

15.1.7.5. Strategy Overview

15.1.7.5.1. Marketing Strategy

15.1.8. HERDEGEN

15.1.8.1. Overview

15.1.8.2. Product Portfolio

15.1.8.3. Profitability by Market Segments

15.1.8.4. Sales Footprint

15.1.8.5. Strategy Overview

15.1.8.5.1. Marketing Strategy

15.1.9. Honigberg International

15.1.9.1. Overview

15.1.9.2. Product Portfolio

15.1.9.3. Profitability by Market Segments

15.1.9.4. Sales Footprint

15.1.9.5. Strategy Overview

15.1.9.5.1. Marketing Strategy

15.1.10. DeVilbiss Healthcare

15.1.10.1. Overview

15.1.10.2. Product Portfolio

15.1.10.3. Profitability by Market Segments

15.1.10.4. Sales Footprint

15.1.10.5. Strategy Overview

15.1.10.5.1. Marketing Strategy

15.1.11. Krug Inc.

15.1.11.1. Overview

15.1.11.2. Product Portfolio

15.1.11.3. Profitability by Market Segments

15.1.11.4. Sales Footprint

15.1.11.5. Strategy Overview

15.1.11.5.1. Marketing Strategy

16. Assumptions & Acronyms Used

17. Research Methodology

List of Tables

Table 01: Global Market Value (US$ Mn) Forecast by Region, 2017-2032

Table 02: Global Market Value (US$ Mn) Forecast by Indication, 2017-2032

Table 03: Global Market Value (US$ Mn) Forecast by End User, 2017-2032

Table 04: North America Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 05: North America Market Value (US$ Mn) Forecast by Indication, 2017-2032

Table 06: North America Market Value (US$ Mn) Forecast by End User, 2017-2032

Table 07: Latin America Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 08: Latin America Market Value (US$ Mn) Forecast by Indication, 2017-2032

Table 09: Latin America Market Value (US$ Mn) Forecast by End User, 2017-2032

Table 10: Europe Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 11: Europe Market Value (US$ Mn) Forecast by Indication, 2017-2032

Table 12: Europe Market Value (US$ Mn) Forecast by End User, 2017-2032

Table 13: Asia Pacific Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 14: Asia Pacific Market Value (US$ Mn) Forecast by Indication, 2017-2032

Table 15: Asia Pacific Market Value (US$ Mn) Forecast by End User, 2017-2032

Table 16: MEA Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 17: MEA Market Value (US$ Mn) Forecast by Indication, 2017-2032

Table 18: MEA Market Value (US$ Mn) Forecast by End User, 2017-2032

List of Charts

Figure 01: Global Market Value (US$ Mn) by Indication, 2022-2032

Figure 02: Global Market Value (US$ Mn) by End User, 2022-2032

Figure 03: Global Market Value (US$ Mn) by Region, 2022-2032

Figure 04: Global Market Value (US$ Mn) Analysis by Region, 2017-2032

Figure 05: Global Market Value Share (%) and BPS Analysis by Region, 2022-2032

Figure 06: Global Market Y-o-Y Growth (%) Projections by Region, 2022-2032

Figure 07: Global Market Value (US$ Mn) Analysis by Indication, 2017-2032

Figure 08: Global Market Value Share (%) and BPS Analysis by Indication, 2022-2032

Figure 09: Global Market Y-o-Y Growth (%) Projections by Indication, 2022-2032

Figure 10: Global Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 11: Global Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 12: Global Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 13: Global Market Attractiveness by Indication, 2022-2032

Figure 14: Global Market Attractiveness by End User, 2022-2032

Figure 15: Global Market Attractiveness by Region, 2022-2032

Figure 16: North America Market Value (US$ Mn) by Indication, 2022-2032

Figure 17: North America Market Value (US$ Mn) by End User, 2022-2032

Figure 18: North America Market Value (US$ Mn) by Country, 2022-2032

Figure 19: North America Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 20: North America Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 21: North America Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 22: North America Market Value (US$ Mn) Analysis by Indication, 2017-2032

Figure 23: North America Market Value Share (%) and BPS Analysis by Indication, 2022-2032

Figure 24: North America Market Y-o-Y Growth (%) Projections by Indication, 2022-2032

Figure 25: North America Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 26: North America Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 27: North America Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 28: North America Market Attractiveness by Indication, 2022-2032

Figure 29: North America Market Attractiveness by End User, 2022-2032

Figure 30: North America Market Attractiveness by Country, 2022-2032

Figure 31: Latin America Market Value (US$ Mn) by Indication, 2022-2032

Figure 32: Latin America Market Value (US$ Mn) by End User, 2022-2032

Figure 33: Latin America Market Value (US$ Mn) by Country, 2022-2032

Figure 34: Latin America Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 35: Latin America Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 36: Latin America Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 37: Latin America Market Value (US$ Mn) Analysis by Indication, 2017-2032

Figure 38: Latin America Market Value Share (%) and BPS Analysis by Indication, 2022-2032

Figure 39: Latin America Market Y-o-Y Growth (%) Projections by Indication, 2022-2032

Figure 40: Latin America Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 41: Latin America Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 42: Latin America Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 43: Latin America Market Attractiveness by Indication, 2022-2032

Figure 44: Latin America Market Attractiveness by End User, 2022-2032

Figure 45: Latin America Market Attractiveness by Country, 2022-2032

Figure 46: Europe Market Value (US$ Mn) by Indication, 2022-2032

Figure 47: Europe Market Value (US$ Mn) by End User, 2022-2032

Figure 48: Europe Market Value (US$ Mn) by Country, 2022-2032

Figure 49: Europe Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 50: Europe Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 51: Europe Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 52: Europe Market Value (US$ Mn) Analysis by Indication, 2017-2032

Figure 53: Europe Market Value Share (%) and BPS Analysis by Indication, 2022-2032

Figure 54: Europe Market Y-o-Y Growth (%) Projections by Indication, 2022-2032

Figure 55: Europe Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 56: Europe Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 57: Europe Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 58: Europe Market Attractiveness by Indication, 2022-2032

Figure 59: Europe Market Attractiveness by End User, 2022-2032

Figure 60: Europe Market Attractiveness by Country, 2022-2032

Figure 61: Asia Pacific Market Value (US$ Mn) by Indication, 2022-2032

Figure 62: Asia Pacific Market Value (US$ Mn) by End User, 2022-2032

Figure 63: Asia Pacific Market Value (US$ Mn) by Country, 2022-2032

Figure 64: Asia Pacific Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 65: Asia Pacific Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 66: Asia Pacific Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 67: Asia Pacific Market Value (US$ Mn) Analysis by Indication, 2017-2032

Figure 68: Asia Pacific Market Value Share (%) and BPS Analysis by Indication, 2022-2032

Figure 69: Asia Pacific Market Y-o-Y Growth (%) Projections by Indication, 2022-2032

Figure 70: Asia Pacific Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 71: Asia Pacific Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 72: Asia Pacific Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 73: Asia Pacific Market Attractiveness by Indication, 2022-2032

Figure 74: Asia Pacific Market Attractiveness by End User, 2022-2032

Figure 75: Asia Pacific Market Attractiveness by Country, 2022-2032

Figure 76: MEA Market Value (US$ Mn) by Indication, 2022-2032

Figure 77: MEA Market Value (US$ Mn) by End User, 2022-2032

Figure 78: MEA Market Value (US$ Mn) by Country, 2022-2032

Figure 79: MEA Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 80: MEA Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 81: MEA Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 82: MEA Market Value (US$ Mn) Analysis by Indication, 2017-2032

Figure 83: MEA Market Value Share (%) and BPS Analysis by Indication, 2022-2032

Figure 84: MEA Market Y-o-Y Growth (%) Projections by Indication, 2022-2032

Figure 85: MEA Market Value (US$ Mn) Analysis by End User, 2017-2032

Figure 86: MEA Market Value Share (%) and BPS Analysis by End User, 2022-2032

Figure 87: MEA Market Y-o-Y Growth (%) Projections by End User, 2022-2032

Figure 88: MEA Market Attractiveness by Indication, 2022-2032

Figure 89: MEA Market Attractiveness by End User, 2022-2032

Figure 90: MEA Market Attractiveness by Country, 2022-2032

November 2017

REP-GB-5523

July 2022

342 pages

Healthcare

Sabyasachi Ghosh

Book Now

Clients

Customize This Research

Quick Contact

Chat on Whatsapp + 44 (0) 20 3287 4268 + 44 (0) 20 8123 9659 + 1 347 918 3531 Contact By Email

- Trust FMI -

- Member of -

Greater New York Chamber of Commerce

- Awarded by -

BRONZE STEVIE® Award

20th annual IBAs

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

- Recognized by -

Patient Recliners Market

Patient Recliners Market By Type, Application, End users - Forecast 2022-2032